Crohn’s & Colitis Congress™
Tweet
Sessions
Speakers
Exhibitors
Floor Plan
Buzz
Speakers
(271)
List
Clara Abraham MD
Event Details
Advancing Findings in Immunology
Hamzah Abu-Sbeih
Event Details
P053 - IMMUNO-CHECKPOINT INHIBITORS INDUCED COLITIS TREATED WITH MESALAMINE
Jeremy Adler MD, MSc
Event Details
Case Discussion Debrief
Dr. Jeremy Adler
Event Details
2 - TREATMENT OF PEDIATRIC CROHN’S DISEASE PATIENTS WITH EARLY PERIANAL COMPLICATIONS
Anita Afzali
Event Details
P089 - PERCEPTIONS REGARDING USE OF ANTI-TUMOR NECROSIS FACTOR TREATMENTS FOR WOMEN OF CHILDBEARING AGE AMONG HEALTHCARE PROFESSIONALS
28 - CHARACTERISTICS AND OUTCOMES OF PROSPECTIVELY REPORTED PREGNANCIES EXPOSED TO CERTOLIZUMAB PEGOL FROM A SAFETY DATABASE
Manasi Agrawal
Event Details
P093 - PREDICTORS OF ANTIDEPRESSANT USE IN INFLAMMATORY BOWEL DISEASE IN A LARGE, RETROSPECTIVE HOSPITAL DATABASE
P126 - TRANSVERSE MYELITIS AFTER VEDOLIZUMAB INDUCTION
Dr. Jose Aguirre
Event Details
6 - MATRIX METALLOPROTEINASE MEDIATED CLEAVAGE OF SURFACE PD-L1 ON (MYO)FIBROBLAST CONTRIBUTES TO THE DYSREGULATION OF T-CELL RESPONSES IN CROHN’S DISEASE
Ezzat Ahmed
Event Details
P112 - STUDY OF THE PROTEOMIC PROFILE IN PATIENTS WITH ULCERATIVE COLITIS, ITS CORRELATION WITH DIAGNOSIS AND DISEASE ACTIVITY
P113 - STUDY OF THE PROTEOMIC PROFILE IN PATIENTS WITH ULCERATIVE COLITIS, ITS CORRELATION WITH DIAGNOSIS AND DISEASE ACTIVITY
Badr Al Bawardy
Event Details
P167 - VEDOLIZUMAB TROUGH LEVELS AND ANTIBODIES IN INFLAMMATORY BOWEL DISEASE: UPDATED INITIAL EXPERIENCE
Dr. Lindsey Albenberg
Event Details
P004 - A DIET LOW IN RED AND PROCESSED MEATS DOES NOT REDUCE THE RATE OF CROHN’S DISEASE FLARES IN A RANDOMIZED CONTROLLED TRIAL: RESULTS OF THE FOOD AND CROHN’S DISEASE EXACERBATION STUDY (FACES)
Dr. Rana Al-Sadi
Event Details
P071 - MECHANISM OF MMP-9 ACTIVATION OF MYOSIN LIGHT CHAIN KINASE (MLCK) MEDIATED DISRUPTION OF INTESTINAL TIGHT JUNCTION BARRIER
Najwan Alsulaimi
Event Details
P132 - A DEEPER LOOK INTO MEDICAL FOODS: WHERE IS THE BEST PATIENT-CENTERED INFORMATION?
Dr. David Alvarado
Event Details
P059 - INDOLEAMINE 2,3-DIOXYGENASE 1 EXPRESSION PROMOTES EPITHELIAL SECRETORY CELL DIFFERENTIATION VIA ARYL HYDROCARBON RECEPTOR
Ashwin Ananthakrishnan MBBS, MPH
Event Details
The Multidisciplinary Care of the Complicated IBD Patient
The Multidisciplinary Care of the Complicated IBD Patient (repeated)
Ashish Atreja
Event Details
P057 - IMPROVED QUALITY OF CARE AND QUALITY OF LIFE FOR IBD PATIENTS USING MOBILE BASED REMOTE MONITORING PLATFORM: A RANDOMIZED CONTROL TRIAL
Dr. Jordan Axelrad
Event Details
P181 - ENTERIC INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: ENDOSCOPIC AND HISTOLOGIC FINDINGS DO NOT DIFFERENTIATE INFECTION FROM FLARE
Dr. Fares Ayoub
Event Details
P177 - EFFECTS OF PRE-OPERATIVE USE OF BIOLOGIC AGENTS ON INTRA-OPERATIVE BLOOD LOSS, OPERATIVE TIME AND LENGTH OF SMALL BOWEL RESECTION IN CROHN'S DISEASE PATIENTS
Veronica Azcutia
Event Details
P017 - CD47 REGULATES CD11B-DEPENDENT NEUTROPHIL TRANSEPITHELIAL MIGRATION DURING INTESTINAL INFLAMMATION
Dr. Danika Bakke
Event Details
18 - MYELOID VITAMIN D RECEPTOR SIGNALING REGULATES PANETH CELL FUNCTION AND INTESTINAL HOMEOSTASIS
Robert N. Baldassano MD
Event Details
Can Diet Be Used to Treat Pediatric IBD?
P014 - AVERAGE ANNUAL HEALTHCARE COSTS FOR PEDIATRIC AND ADULT PATIENTS WITH CROHN’S DISEASE OR ULCERATIVE COLITIS
Dr. Adebowale Bamidele
Event Details
15 - DISRUPTION OF FOXP3-EZH2 INTERACTION BY GENETIC MUTATION OR SIGNALING-INDUCED INACTIVATION REPRESENTS A NOVEL PATHOBIOLOGICAL MECHANISM IN INFLAMMATORY BOWEL DISEASE
Dr. Edward Barnes
Event Details
P170 - A NOVEL PATIENT REPORTED QUALITY OF LIFE MEASURE CORRELATES WELL WITH THE SHORT INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE IN A LARGE INTERNET BASED COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
12 - HIGH PATIENT ACTIVATION IS ASSOCIATED WITH CLINICAL REMISSION IN A LONGITUDINAL ANALYSIS OF A LARGE INTERNET BASED COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Dr. Margaux Barnes
Event Details
P098 - RELATIONS BETWEEN HEALTH BEHAVIORS, BODY COMPOSITION AND DISEASE STATUS IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Laura Bauman
Event Details
13 - REFINED POPULATION PHARMACOKINETIC MODEL FOR INFLIXIMAB PRECISION DOSING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
James Bayrer MD, PhD
Event Details
Sneak Peek into a Basic Grant Review Panel - Grant Proposal Presentation and Mock Study
Meenakshi Bewtra, MD, PhD, MPH
Event Details
Clincial Quick Shots Breakout
Ashley Bochenek Perkovic APN, FNP
Event Details
Care of the Medically Complex Patient
Moheb Boktor
Event Details
P068 - LIPID PHOSPHATE PHOSPHATASE-3 (LPP3) DEFICIENCY INTENSIFIES INTESTINAL INFLAMMATION IN THE DSS MODEL OF ULCERATIVE COLITIS: ROLES OF LYSOPHOSPHATIDIC ACID AND LYMPHATIC/VASCULAR NETWORKS IN INFLAMMATORY GUT INJURY?
Dr. Marie Borum
Event Details
P001 - #IBD: A WORD ASSOCIATION ANALYSIS OF TWEETS ABOUT INFLAMMATORY BOWEL DISEASE
P009 - A RARE CASE OF A GASTRIC ABSCESS FISTULIZING TO THE DUODENUM IN CROHN’S DISEASE
P021 - COMPLEMENTARY AND ALTERNATIVE MEDICINE IN INFLAMMATORY BOWEL DISEASE: WHERE'S THE DISCUSSION?
P024 - CROHN’S DISEASE MESSAGING ON TWITTER: WHO’S TALKING?
P034 - EXERCISE AS ADJUNCTIVE THERAPY IN INFLAMMATORY BOWEL DISEASE: AN EDUCATIONAL INTERVENTION CAN INCREASE PHYSICIAN AWARENESS
P061 - INFLAMMATORY BOWEL DISEASE SEVERITY INFLUENCES VITAMIN D MONITORING
P082 - OCULAR EVALUATIONS IN INFLAMMATORY BOWEL DISEASE: STEROID USE AND PATIENT ETHNICITY INFLUENCE REFERRAL RATES
P090 - PHYSICAL ACTIVITY IS INFREQUENTLY ASSESSED IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
P091 - PHYSICIANS INCONSISTENTLY MONITOR VITAMIN D IN INFLAMMATORY BOWEL DISEASE PATIENTS: GENDER AND ETHNICITY MAY PLAY A ROLE
P108 - SLEEP DISORDERS IN INFLAMMATORY BOWEL DISEASE: THE FORGOTTEN DISCUSSION
P131 - VITAMIN D DEFICIENCY MAY BE ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE EXACERBATIONS
P159 - SEARCHING FOR MORE: THE NEED FOR HIGH-QUALITY INFORMATION AND PATIENT-CENTERED LANGUAGE IN ONLINE RESOURCES FOR MEDICAL FOODS IN IBD
Athos Bousvaros MD, AGAF
Event Details
Adolescent, Young Adults and Pregnant Patients with IBD
Adolescent, Young Adults and Pregnant Patients with IBD (repeated)
Joshua Boyer
Event Details
P062 - INTEGRIN ß7 DEFICIENCY RESULTS IN PAUCITY OF TERTIARY LYMPHOID TISSUES AND DECREASED LAMINA PROPRIA IGA+ B CELLS LEADING TO MICROBIOME DYSBIOSIS AND WORSE INFLAMMATION IN A MODEL OF CROHN’S-LIKE ILEITIS
Jonathan Braun MD, PhD, AGAF
Event Details
Fecal Metabolomic Analysis: Ready for Clinical Use?
Jacqui Brooks
Event Details
P195 - THE GASTROENTEROLOGY LEARNER PATHWAY IN IBD: AN OUTCOMES-BASED ITERATIVE APPROACH TO IBD EDUCATION USING ADVANCED ANALYTICS AND PREDICTIVE MODELING TO SUSTAIN BEHAVIORAL CHANGE
Robert Burakoff MD, MPH, AGAF
Event Details
Clinical Challenges You Face Every Day
Dr. Juan Burgueno
Event Details
P125 - TLR4 ACTIVATION UPREGULATES EXPRESSION OF OXIDATIVE ENZYMES: IMPLICATIONS FOR INTESTINAL TUMORIGENESIS AND LUMINAL MICROBIOTA
Dr. Ludovica Butto
Event Details
P104 - ROLE OF TL1A AND ITS RECEPTOR DR3 IN REGULATING INTESTINAL TH9 CELL DIFFERENTIATION IN CROHN’S DISEASE (CD)-LIKE ILEITIS
Dr. Christopher Cardinale
Event Details
P027 - DIFFERENTIAL BINDING OF RBPJ AND CUX1 TO IBD CAUSAL SNP rs1887428 MODIFIES EXPRESSION OF JAK2
Ms Joana Castela
Event Details
P022 - CROHN’S DISEASE AND ACUTE B LYMPHOBLASTIC LEUKEMIA – COINCIDENCE OR ASSOCIATION?
P127 - ULCERATIVE COLITIS AND PAPILLARY THYROID CARCINOMA – IS THERE AN ASSOCIATION?
Karen A. Chachu MD, PhD
Event Details
The Lloyd Mayer, MD, Young IBD Investigators Clinical, Basic and Translational Research Workshop
Closing Remarks
Dr. Ji Young Chang
Event Details
P099 - RESPONSE OF HEPATITIS B VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE; PROSPECTIVE OBSERVATIONAL STUDY IN KOREA
Dr. Victor Chedid
Event Details
P100 - RITUXIMAB-INDUCED COLITIS: THE MAYO CLINIC EXPERIENCE
Adam S. Cheifetz MD, AGAF
Event Details
Optimizing Outcomes and Therapeutic Drug Monitoring
Challenges in Monitoring Response
Dr. Baosheng Chen
Event Details
P096 - RADIATION AND IDO1-SELECTIVE INHIBITOR EPACADOSTAT EXHIBIT THERAPEUTIC SYNERGY IN COLITIS ASSOCIATED CANCER
Michael Chiorean
Event Details
P144 - ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF THERAPY TO ADALIMUMAB, INFIXIMAB OR OTHER ANTI-TNF COMPARED WITH SWITCHING FROM ANTI-TNF THERAPY TO VEDOLIZUMAB
Judy Cho MD
Event Details
Concept and Findings of the Foundation’s Update to “Challenges in IBD”
Kati Choi
Event Details
P016 - CASE SERIES: IMMUNOTHERAPY-INDUCED LYMPHOCYTIC COLITIS
P114 - SYSTEMIC STEROIDS IN ANTI-PD1-INDUCED COLLAGENOUS COLITIS
Mr. Aaron Chow
Event Details
P031 - ENTERIC GLIA SHARE CHARACTERISTICS WITH ANTIGEN PRESENTING CELLS AND MAY ALTER SERUM CHEMOKINE LEVELS DURING NEUROINFLAMMATION
Dr. George Christophi
Event Details
P165 - UTILIZATION OF REACTIVE DRUG LEVEL MONITORING IN INFLAMMATORY BOWEL DISEASE
Jennifer Claytor
Event Details
P015 - BODY IMAGE DISSATISFACTION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASES
Benjamin Cohen
Event Details
The Lloyd Mayer, MD, Young IBD Investigators Clinical, Basic and Translational Research Workshop
Closing Remarks
Dr. Shirley Cohen-Mekelburg
Event Details
P083 - OPIOID DEPENDENCE IS ON THE RISE AMONG IBD HOSPITALIZATIONS
7 - FRAGMENTED CARE IS PREVALENT AMONG IBD HOSPITALIZATIONS AND IS ASSOCIATED WITH WORSE OUTCOME
Jean Frederic Colombel MD
Event Details
Sneak Peek into a Clinical Grant Review Panel - Grant Proposal Presentation and Mock Study
Multidisciplinary Panel Review of Cases
Fabio Cominelli MD, PhD
Event Details
Sneak Peek into a Basic Grant Review Panel - Grant Proposal Presentation and Mock Study
Highlight: One Basic Research Theme, One Clinical Research Theme in 2017
Challenges in Monitoring Response
Basic Theme
Laurie Conklin
Event Details
P036 - EXPLORING EARLY-RESPONSIVE PHARMACODYNAMIC BIOMARKERS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (IBD)
Sheila E. Crowe MD, AGAF
Event Details
Welcome
Dr. Valerie Curtis
Event Details
P030 - ENPP1 EXPRESSION IN GUT MUCOSAL EPITHELIA INFLUENCES BARRIER FUNCTION VIA THE ADENOSINE PATHWAY
Ms Natalia Danilova
Event Details
P110 - STEROID-RESISTANCE AND STEROID-DEPENDENCE IN INFLAMMATORY BOWEL DISEASE CAN BE LINKED WITH GUT MICROBIOTA COMPOSITION CHANGES
Lee A. Denson MD
Event Details
Keynote Research Presentation: Biomarkers for Precision Medicine
Dr. Suzanne Devkota
Event Details
17 - SINGLE-CELL SEQUENCING OF CREEPING FAT IN CROHN’S DISEASE REVEALS DISTINCT IMMUNE CLUSTERS AND CELLULAR RESTRUCTURING IN THE PRESENCE OF LIVE BACTERIA AND FUNGI
Dr. Nikhita Dharbhamulla
Event Details
P174 - CLOSTRIDIUM DIFFICILE IN INFLAMMATORY BOWEL DISEASE: WHICH TREATMENT REGIMEN IS SUPERIOR?
Dr. Adam Dhedhi
Event Details
P207 - CLINICAL PREDICTORS OF RESPONSE TO VEDOLIZUMAB TREATMENT IN CROHN’S DISEASE
Luca Di Martino
Event Details
P040 - FIBROBLAST GROWTH FACTOR-INDUCIBLE 14 (FN14) SIGNALING MEDIATES CROHN’S DISEASE (CD)-LIKE ILEITIS IN SAMP MICE
Garrett Diltz
Event Details
P081 - NEUTROPHILIC PUSTULOSIS OF ULCERATIVE COLITIS: A SPECTRUM OF EXTRAINTESTINAL DISEASE
Bethany Doerfler MS, RD, LDN
Event Details
The Multidisciplinary Care of the Complicated IBD Patient
The Multidisciplinary Care of the Complicated IBD Patient (repeated)
Dr. Jean Donet
Event Details
P013 - APOPTOTIC ENTEROPATHY INDUCED BY THALIDOMIDE IN A PATIENT WITH REFRACTORY UPPER AND COLONIC CROHNS’ DISEASE
P130 - VEDOLIZUMAB-INDUCED BULLOUS PEMPHIGUS IN A PATIENT WITH ULCERATIVE COLITIS
Nicole Doria
Event Details
P157 - REPLICATING THE PATIENT’S APPROACH: A SEARCH FOR MEDICAL FOODS IN IBD
Dr. Jennifer Dotson
Event Details
P153 - PATIENT, PARENT, AND PROVIDER PERCEPTIONS OF BARRIERS TO PEDIATRIC INFLAMMATORY BOWEL DISEASE CARE
Shishir Dube
Event Details
P176 - COMPLICATED CROHN’S DISEASE IS ASSOCIATED WITH PERIANAL INVOLVEMENT, IBD-ASSOCIATED SEROLOGIES, AND POLYGENIC RISK SCORES DERIVED FROM IBD-ASSOCIATED VARIANTS
Marla Dubinsky MD
Event Details
Asymptomatic but Ongoing Inflammation — What Now and Does Age Matter?
Sharon L. Dudley-Brown PhD, FNP-BC, CRNP
Event Details
Balancing Research and Scholarly Activities with Practice
Parambir Dulai
Event Details
P166 - VEDOLIZUMAB MARKET ACCESS ANALYSIS OF HEALTH INSURANCE IBD POLICIES
Dr. Adam Ehrlich
Event Details
P198 - TRAINEES IN GASTROENTEROLOGY AND MATERNAL-FETAL MEDICINE HAVE MORE PREGNANCY-RELATED IBD KNOWLEDGE COMPARED WITH TRAINEES IN INTERNAL MEDICINE OR OBSTETRICS-GYNECOLOGY
Derrick Eichele
Event Details
P175 - COLORECTAL CANCER RISK IN INFLAMMATORY BOWEL DISEASE FOLLOWING LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS
Jessica Elia
Event Details
P054 - IMPACT OF INFLAMMATORY BOWEL DISEASE ON PHYSICAL MOBILITY AND QUALITY OF LIFE: PHYSICIAN AND PATIENT PHYSICAL REHABILITATION PERSPECTIVES DIVERGE
Najwa El-Nachef MD
Event Details
FMT for the Inflammatory Bowel Diseases: Ulcerative Colitis, Crohn’s Disease and Pouchitis
Francis A. Farraye MD, MSc, AGAF
Event Details
Perspectives: IBD Review for Professionals ($$)
Welcome and Introduction
Understanding Risks of IBD Therapies and Minimizing Risk
Physician Panel — Case Discussions and Question and Answer
William A. Faubion MD
Event Details
Management of Perianal and Pouch Complications
Management of Perianal and Pouch Complications (repeated)
Steven Feldman
Event Details
P210 - GASTROINTESTINAL SYMPTOMS ARE COMMON IN U.S. PATIENTS WITH MODERATE-SEVERE PSORIASIS
Marc Fenster
Event Details
P163 - TRANSITION TO BIOLOGIC HOME INFUSIONS IN IBD PATIENTS IS ASSOCIATED WITH HIGH DROP OUT WITHIN ONE YEAR
Alessandro Fichera MD
Event Details
Multidisciplinary Panel Review of Cases
Management of Perianal and Pouch Complications
Management of Perianal and Pouch Complications (repeated)
Monika Fischer MD
Event Details
Managing FMT Non-Responders and Adverse Events
Joel G. Fletcher MD
Event Details
Management of Perianal and Pouch Complications
Management of Perianal and Pouch Complications (repeated)
Dr. Delfin Lovelina Francis
Event Details
P085 - ORAL HEALTH STATUS OF ULCERATIVE COLITIS PATIENTS: A COMPARATIVE STUDY
Kendra Francis
Event Details
P192 - SURGICAL OUTCOMES IN CHILDREN HOSPITALIZED WITH UC RECEIVING INTENSIFIED INFLIXIMAB INDUCTION
Dr. Yezaz Ghouri
Event Details
P171 - AUTOIMMUNE DISORDERS AFTER PROCTOCOLECTOMY IN ULCERATIVE COLITIS
P180 - ENDOSCOPIC CORRECTION OF TWISTED POUCH RELATED STENOSIS
Jeffrey Goldsmith
Event Details
Management of Perianal and Pouch Complications
Management of Perianal and Pouch Complications (repeated)
Dr. Wendy Goodman
Event Details
5 - LOSS OF ESTROGEN RECEPTOR BETA IN A SPONTANEOUS MODEL OF CROHN'S-LIKE ILEITIS REVEALS SEX-SPECIFIC FUNCTIONS OF ESTROGEN SIGNALING AMONG INTESTINAL REGULATORY T CELLS
Shail Govani
Event Details
P010 - ADHERENCE TO INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASE, A MULTICENTER RETROSPECTIVE REVIEW
Dr. Nicole Green
Event Details
3 - ENDOSCOPIC AND HISTOLOGIC SCORES AS PREDICTORS OF PROGRESSION TO COLECTOMY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS
Matthew Grisham
Event Details
Basic Quick Shots Breakout
Vladimir Grubisic
Event Details
P041 - GLIAL CONNEXIN-43 REGULATES NEURO-IMMUNE INTERACTIONS IN THE MOUSE COLON
Dr. Vineet Gudsoorkar
Event Details
P133 - AN ANALYSIS OF SURGICAL OUTCOMES IN IBD PATIENTS TREATED WITH AND WITHOUT BIOLOGIC THERAPY
P134 - BEYOND THE “BIG PICTURE”: CAN MICRONUTRIENTS IMPACT SURGICAL OUTCOMES IN IBD?
Dr. Zhen Guo
Event Details
P143 - EARLY VERSUS DELAYED INITIATION OF POSTOPERATIVE PHARMACOLOGICAL PROPHYLAXIS TO PREVENT SURGICAL RECURRENCE AFTER INTESTINAL RESECTION IN PATIENTS WITH CROHN’S DISEASE
Neera Gupta MD, MAS
Event Details
Cutting-Edge Pediatric IBD ($$)
Welcome and Introduction
Clinical Case Presentation 2: Boy on Methotrexate with Hypoalbuminemia, Growth Failure Starting Anti-TNF — What Dose, Combination Therapy? Do I Check Levels?
Case Discussion Debrief
Christina Ha MD
Event Details
The Lloyd Mayer, MD, Young IBD Investigators Clinical, Basic and Translational Research Workshop
Closing Remarks
Adolescent, Young Adults and Pregnant Patients with IBD
Adolescent, Young Adults and Pregnant Patients with IBD (repeated)
Leonard Haas
Event Details
P147 - IMPLEMENTATION OF A NEW ORAL CONTRAST AGENT FOR CT AND MR ENTEROGRAPHY IN PEDIATRIC IBD CLINICAL PRACTICE: IMPACT ON TOLERABILITY, DISTENSION, IMAGE QUALITY AND DIAGNOSTIC CONFIDENCE
Dr. Bill Hacker
Event Details
P216 - WHAT IS THE RATE OF CHRONIC OPIOID USE AND HOW IT IMPACTS HEALTHCARE UTILIZATION WITHIN AN IBD CLINIC POPULATION
Dr. Muhammad Hammami
Event Details
P065 - INTERNISTS’ PRACTICE AND PERCEPTIONS OF RESPONSIBILITY OF IBD-RELATED HEALTH MAINTENANCE
P202 - VACCINATIONS IN IBD PATIENTS: GASTROENTEROLOGISTS’ VS. INTERNISTS’ PRACTICE AND PERCEPTIONS OF RESPONSIBILITY
P203 - VEDOLIZUMAB IS SAFE AFTER ANTI-TNF-ASSOCIATED PULMONARY TUBERCULOSIS IN CROHN'S DISEASE: CASE REPORT
Dr. Xiaonan Han
Event Details
P097 - REGULATION OF PANETH CELL LINEAGES FOR REGIONAL IMMUNE SPECIALIZATION TO CONTROL COMORBIDITY OF C. DIFFICILE INFECTION WITH IBD
Gail A. Hecht MD, MS, AGAF
Event Details
A Clinician’s Guide to Fecal Microbiota Transplant (FMT) ($$)
Welcome and Introduction
Page
1
of
3
Home
Sessions
Speakers
Exhibitors
Floor Plan
Tweet
Login
|
Back to top
ChirpE